# CorMedix Inc.: Form D filings

CorMedix Inc., a pharmaceuticals company in Bridgewater, NJ, filed 2 Form D notices with the SEC between 2009 and 2012. The latest, on October 3, 2012, reports $850,000 sold of a $3 million offering to 8 investors.

Find out what CorMedix Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CorMedix%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CorMedix%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcormedix-inc-1410098)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CorMedix%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CorMedix%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcormedix-inc-1410098)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 745 ROUTE 202-206, SUITE 303, Bridgewater, NJ, 08807
- Phone: (908) 517-9500
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1410098

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 3, 2012 | New notice | $3,000,000 | $850,000 | $2,150,000 | 8 | Sep 11, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1410098/000114420412054400/0001144204-12-054400-index.htm) |
| Nov 13, 2009 | New notice | $2,700,000 | $2,619,973 | $80,027 | 19 | Oct 29, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1410098/000141009809000002/0001410098-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Anthony E. Pfaffle | Director |  |
| Matthew W. Duffy | Director |  |
| Steven W. Lefkowitz | Director |  |
| Richard M. Cohen | Executive Officer, Director |  |
| Timothy A. Hofer | Director |  |
| Gary A. Gelbfish | Director |  |
| Randy W. Milby | Executive Officer |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of Oct 1, 2012](https://specstream.ai/data/form-d/week/2012-10-01) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what CorMedix Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).